DE

458.36

+0.35%↑

CTAS

187.99

+2.1%↑

FDX

238.06

+0.58%↑

PAYX

126.55

+0.1%↑

CPRT

44.33

+0.64%↑

DE

458.36

+0.35%↑

CTAS

187.99

+2.1%↑

FDX

238.06

+0.58%↑

PAYX

126.55

+0.1%↑

CPRT

44.33

+0.64%↑

DE

458.36

+0.35%↑

CTAS

187.99

+2.1%↑

FDX

238.06

+0.58%↑

PAYX

126.55

+0.1%↑

CPRT

44.33

+0.64%↑

DE

458.36

+0.35%↑

CTAS

187.99

+2.1%↑

FDX

238.06

+0.58%↑

PAYX

126.55

+0.1%↑

CPRT

44.33

+0.64%↑

DE

458.36

+0.35%↑

CTAS

187.99

+2.1%↑

FDX

238.06

+0.58%↑

PAYX

126.55

+0.1%↑

CPRT

44.33

+0.64%↑

Search

Xylem Inc-NY

Uždarymo kaina

SektoriusPramonės sektorius

145.85 0.89

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

144

Max

146.12

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-338M

-169M

Pardavimai

232M

2.3B

P/E

Sektoriaus vid.

38.021

38.737

Dividendų pajamingumas

1.05

Pelno marža

-7.345

Darbuotojai

23,000

EBITDA

83M

453M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+12.06% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.05%

2.52%

Kitas uždarbis

2025-10-28

Kita Ex Dividend data

2025-11-25

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.4B

36B

Ankstesnė atidarymo kaina

144.96

Ankstesnė uždarymo kaina

145.85

Naujienos nuotaikos

By Acuity

32%

68%

119 / 457 reitingas Industrials

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

Xylem Inc-NY Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-17 18:13; UTC

Pagrindinės rinkos jėgos

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

2025-10-17 17:05; UTC

Pagrindinės rinkos jėgos

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

2025-10-17 15:03; UTC

Pagrindinės rinkos jėgos

Obook Shares Sink Following Public Debut

2025-10-17 14:41; UTC

Pagrindinės rinkos jėgos

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

2025-10-17 23:25; UTC

Įsigijimai, susijungimai, perėmimai

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

2025-10-17 22:15; UTC

Rinkos pokalbiai

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

2025-10-17 21:15; UTC

Rinkos pokalbiai

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

2025-10-17 21:07; UTC

Rinkos pokalbiai

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

2025-10-17 21:07; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-17 20:34; UTC

Rinkos pokalbiai

Deere Is Reaching the End of Its Downcycle -- Market Talk

2025-10-17 20:27; UTC

Rinkos pokalbiai

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

2025-10-17 19:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

2025-10-17 19:45; UTC

Rinkos pokalbiai

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

2025-10-17 18:45; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

2025-10-17 17:51; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-17 17:51; UTC

Rinkos pokalbiai

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

2025-10-17 17:44; UTC

Rinkos pokalbiai

EQT Seen With Long-Term Growth Opportunities -- Market Talk

2025-10-17 17:35; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

2025-10-17 16:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-10-17 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-17 16:14; UTC

Rinkos pokalbiai

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

2025-10-17 16:04; UTC

Rinkos pokalbiai

Home Improvement Demand Is Starting to Pick Up -- Market Talk

2025-10-17 15:58; UTC

Rinkos pokalbiai

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

2025-10-17 15:56; UTC

Uždarbis

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

2025-10-17 15:43; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-17 15:43; UTC

Rinkos pokalbiai

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

2025-10-17 14:58; UTC

Rinkos pokalbiai

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

2025-10-17 14:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-17 14:35; UTC

Rinkos pokalbiai
Uždarbis

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Akcijų palyginimas

Kainos pokytis

Xylem Inc-NY Prognozė

Kainos tikslas

By TipRanks

12.06% į viršų

12 mėnesių prognozė

Vidutinis 162.3 USD  12.06%

Aukščiausias 175 USD

Žemiausias 130 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Xylem Inc-NY kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

9

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

120.57 / 124.25Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Neutral Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Rinkos nuotaikos

By Acuity

119 / 457 reitingas Pramonės sektorius

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Xylem Inc-NY

Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Xylem Vue, and Flojet brands. The Measurement & Control Solutions segment offers smart meters, networked communication devices, data analytics, test equipment, controls, sensor devices, software and managed services, and critical infrastructure services; and software and services, including cloud-based analytics, remote monitoring and data management, leak detection, condition assessment, asset management, and pressure monitoring solutions, as well as testing equipment. This segment sells its products under the Pure Technologies, Sensus, Smith Blair, WTW, Xylem Vue, and YSI brands. The Integrated Solutions and Services segment provides maintenance services, mobile services, digital outsourced solutions, wastewater systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, ion exchange, and deionization under Aquapro, WaterOne, and Ion Pure brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in May 2011. Xylem Inc. was incorporated in 2011 and is headquartered in Washington, District of Columbia.
help-icon Live chat